MRI Contrast Safety

To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.

Step Status
Video/Document(s)
Posttest
Evaluation
Starts On: 11/27/2019: 12:00 AM
Ends On: 6/30/2020: 12:00 AM
Session Type: Internet Activity Enduring Material
Credits: 1.75
Description:

Faculty

Jamal Derakhshan, MD, PhD
Assistant Professor of Radiology, Washington University School of Medicine
Financial Disclosure: Nothing to disclose

Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Advanced MRI Safety Training & ABMRS Board Prep, September 13-14, 2019.

Planning Committee

Maxwell Amurao, PhD, Director of Radiation Safety, Washington University School of Medicine
Financial Disclosure
Speakers Bureau/Honoraria: Medical Technology Management Institute
Consulting/Advisory Committees: Radcom Associates

Trevor Andrews, PhD, Assistant Professor of Radiology, Washington University School of Medicine MRI Physicist, Barnes-Jewish Hospital
Financial Disclosure: Nothing to disclose

Tammie Benzinger, MD, PhD, Course Chair, Professor of Radiology, MRI Service Director, Washington University School of Medicine
Financial Disclosure
Research Support/Grants: Avid Radiopharmaceuticals Inc, Roche, Janssen Pharmaceuticals, Inc., Eli Lilly and Co,

Sanjeev Bhalla, MD, Independent Reviewer Professor of Radiology Division of Diagnostic Radiology Cardiothoracic Imaging Section Chief, Cardiothoracic Imaging Section Co-Chief, Body Computed Tomography Assistant Radiology Residency Program Director Washington University School of Medicine
Financial Disclosure: Nothing to disclose

Jamal Derakhshan, MD, PhD, Assistant Professor of Radiology, Washington University School of Medicine
Financial Disclosure: Nothing to disclose

Christine Irish, BS, R.T.(R)(MR), MRI Clinical Applications, Barnes-Jewish Hospital
Financial Disclosure: Nothing to disclose

Robert McKinstry, MD, PhD, Professor of Radiology; Director, Division of Diagnostic Radiology Washington University School of Medicine
Financial Disclosure: Nothing to disclose

Michelle Miller-Thomas, MD, Associate Professor of Radiology, Washington University School of Medicine
Financial Disclosure
Research: Biogen Inc

Don Missey R.T.(R)(MR), MRI Supervisor at Barnes-Jewish Hospital
Financial Disclosure: Nothing to disclose

Laurie Oberholtzer, RT(R), MHA, Course Chair, Radiology Program Manager, Barnes-Jewish Hospital
Financial Disclosure: Nothing to disclose

Matthew Parsons, MD, Associate Professor of Radiology, Washington University School of Medicine Director of Neuroimaging, Barnes-Jewish West County Hospital
Financial Disclosure: Nothing to disclose

Monica Sanchez, APRN, FNP-BC Electrophysiology Barnes-Jewish Hospital
Financial Disclosure: Nothing to disclose

Todd Zimbelman BSRT, (MR), MRSO, Supervisor/MRI, Barnes-Jewish Hospital
Financial Disclosure: Nothing to disclose

Objectives: The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
  • List the short and long-term adverse effects associated with gadolinium-based contrast agents.
Additional Information:
Target Audience: This course is designed for physicians, nurses, radiology technologists, physicians in training and other health professionals who work in the MR environment.

Publication Date: November 27, 2019
Expiration Date: June 30, 2020
Accreditation Information:
wustlcme
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of 1.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
References:
  • FDA. FDA warns that GBCAs are retained in the body: requires new class warning. Drug safety communication. Issued 12-19-2017. https://www.fda.gov/media/109825/download
  • Fraum TJ, Ludwig DR, Bashir MR, Fowler KJ. Gadolinium-based contrast agents: A comprehensive risk assessment. J Magn Reson Imaging. 2017 Aug;46(2):338-353
  • Gathings RM, Reddy R, Cruz DS, Brodell RT. Gadolinium associated plaques: a new, distinctive clinical entity. JAMA Dermatology 2015;151(3):316-319
  • Henriques B, Coppola F, Monteiro R, et al. Toxicological assessment of anthropogenic Gadolinium in seawater: Biochemical effects in mussels Mytilus galloprovincialis. Sci Tot Environ 2019;664:626-634.
  • Thomsen HS. Generic gadolinium-based contrast agents: the future? Acta Radiologica 2017;58:1285-7
Disclosure Information: It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.

Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.

Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.

These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.


Powered By AI 4.5